Little joys for everyday · Free shipping over $75
aspirin and glp 1

aspirin and glp 1 GLP-1 Agonists - What is it? Cardiovascular Protective Properties of GLP-1

SKU: 87751201667

4.3
USD20.18 USD46.18

Pay in 4 interest-free payments of $5.04 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 16 - Aug 21

Description

PubMed ID: 10204116 GHRP-2 vs Other GHS-R1a Research Peptides Feature GHRP-2 GHRP-6 Ipamorelin Hexarelin Sequence D-Ala-D-Nal-Ala-Trp-D-Phe-Lys-NH (6aa) His-D-Trp-Ala-Trp-D-Phe-Lys-NH (6aa) Aib-His-D-2-Nal-D-Phe-Lys-NH (5aa) His-D-2-MeTrp-Ala-Trp-D-Phe-Lys-NH (6aa) GHS-R1a Activity More potent than GHRP-6 Potent (founding reference) Potent (most selective) Most potent classic GHRP CD36 Binding Yes (confirmed) Yes (confirmed) Not established Yes (confirmed) ACTH/Cortisol Release Yes (significant) Yes (significant) No (selective GH only) Yes (significant) GHRH Co-Dependency Partial Yes (82% of GH response) Partial Partial GI Motility Research Limited Yes (motilin receptor interaction) Not established Limited Cardioprotection Research Moderate Extensive None Extensive Wound Healing Research None established Published (PPAR/TGF-) None None CD36 Drug Discovery Secondary scaffold Primary scaffold None Secondary Historical Significance High-potency second-generation GHRP Discovery peptide (led to ghrelin) First selective GHRP Most potent classic GHRP GHRP-2s combination of enhanced GHS-R1a potency relative to GHRP-6, confirmed CD36 pharmacology, significant HPA axis co-stimulation, and role as a second-generation comparative reference compound makes it an essential research tool for GH axis biology, pituitary pharmacology, and cytoprotective pathway research occupying a distinct niche from the selective Ipamorelin (no HPA co-stimulation, no CD36), the more extensively CD36-characterised GHRP-6 (lower GHS-R1a potency), and the extremely potent Hexarelin (more restricted research application)

aspirin and glp 1 GLP-1 Agonists - What is it? Cardiovascular Protective Properties of GLP-1

Activation of MC4R in particular is associated with reduced appetite and potential weight loss

aspirin and glp 1 GLP-1 Agonists - What is it? Cardiovascular Protective Properties of GLP-1

Pharmacokinetic Interaction of astragaloside IV with atractylenolide I and prim-O-glucosylcimifugin in male Sprague Dawley rats

aspirin and glp 1 GLP-1 Agonists - What is it? Cardiovascular Protective Properties of GLP-1

SIRT3 siRNA treatment significantly attenuated the protective effects of melatonin on H 2 O 2 -induced mitochondrial ROS generation (Fig

aspirin and glp 1 GLP-1 Agonists - What is it? Cardiovascular Protective Properties of GLP-1
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

eNavvi
eNavvi

US$ 24.14

4.5 (21 reviews)

recommand products